Results for
"[search-keyword]"
Sponsor content
201 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial.
-
Jan-2024Prescription medicine evaluationActive ingredient: alectinib hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Australian Public Assessment Report (AusPAR)Gavreto (pralsetinib) has been approved for the treatment of locally advanced or metastatic RET fusion-positive non-small cell lung cancer.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd